THERAPEUTIC EFFECTS OF FLUDARABINE-CYCLOPHOSPHAMIDE COMBINED THERAPY IN IRANIAN PATIENTS WITH B-CELL CHRONIC LYMPHOCYTIC LEUKEMIA